← 產業報告目錄
GMP Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Product (Viral Vectors, Plasmid DNA, Non-viral, Lipid/polymer, Electroporation, Nanoparticles, Others), By Type, By Application, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-14頁數 180報告編號 INSIGHTACE-d9400a394d
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2024 valuation of USD 212.1 Million, the global GMP Plasmid DNA Manufacturing Market is projected to surge to USD 512.1 Million by 2034, demonstrating a CAGR of 9.3% during the 2025–2034 forecast window.
GMP Plasmid DNA Manufacturing covers reshaping how healthcare entities approach this space.
Growth is bolstered by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global GMP Plasmid DNA Manufacturing Market Snapshot
Chapter 4. Global GMP Plasmid DNA Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product:
5.2.1. Viral Vectors
5.2.1.1. Retroviral
5.2.1.2. Adenoviral
5.2.1.3. Lentiviral
5.2.1.4. Adeno-Associated
5.2.1.5. Others
5.2.2. Plasmid DNA
5.2.3. Non-viral
5.2.4. Lipid/polymer
5.2.5. Electroporation
5.2.6. Nanoparticles
5.2.7. Others
Chapter 6. Market Segmentation 2: By Type Estimates & Trend Analysis
6.1. By Type & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type:
6.2.1. Pre-Clinical Therapeutics
6.2.2. Clinical Therapeutics
6.2.3. Marketed Therapeutics
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
7.2.1. Gene Therapy
7.2.2. DNA Vaccines
7.2.3. Immunotherapy
7.2.4. Others
Chapter 8. GMP Plasmid DNA Manufacturing Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
8.1.2. North America GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.1.3. North America GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.1.4. North America GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
8.2.2. Europe GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.2.3. Europe GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.4. Europe GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
8.3.2. Asia Pacific GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.3.3. Asia Pacific GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.4. Asia Pacific GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.4. Latin America
8.4.1. Latin America GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
8.4.2. Latin America GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.4.3. Latin America GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.4. Latin America GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
8.5.2. Middle East & Africa GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.5.3. Middle East & Africa GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.4. Middle East & Africa GMP Plasmid DNA Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Patheon (Thermo Fisher Scientific)
9.2.2. Cobra Bio
9.2.3. GenScript ProBio
9.2.4. WuXi Advanced Therapies
9.2.5. Charles River
9.2.6. Waisman Biomanufacturing
9.2.7. BioXcellence
9.2.8. LakePharma
9.2.9. Aldevron
9.2.10. Kaneka Eurogentec S.A.
9.2.11. Catalent Biologics
9.2.12. Eurogentec
9.2.13. Nature Technology Corporation
9.2.14. VectorBuilder
9.2.15. VGXI, Inc
9.2.16. PlasmidFactory
9.2.17. Delphi Genetics (Catalent)
9.2.18. Esco Aster
9.2.19. Biovian
9.2.20. Creative Biolabs
9.2.21. Vigene Biosciences (Charles River)
9.2.22. Cognate BioServices (Charles River)
9.2.24. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們